Molecular Partners Ag (MOLN) Interest & Investment Income (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Interest & Investment Income of $395.87 for Q1 2026, down 29.1% year-on-year from $558.35 in Q1 2025, and up 100.01% on a QoQ basis from -$4.4 million in Q4 2025.

Molecular Partners Ag (MOLN) Interest & Investment Income (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Interest & Investment Income for 7 consecutive years, with $395.87 the latest figure, recorded in Q1 2026.

  • Quarterly Interest & Investment Income fell 29.1% year-over-year to $395.87 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.4 million (down 153.29% YoY) and the FY2025 annual result came in at -$4.4 million, down 153.28% from the prior year.
  • Interest & Investment Income climbed to $395.87 in Q1 2026 per MOLN's latest filing, from -$4.4 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for MOLN reached as high as $8.2 million in Q4 2024 and fell as low as -$4.4 million in Q4 2025.
  • A 5-year average of $817261.8 and a median of $1008.5 in 2024 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 840.27% — and 2025, when it plunged 153.33%.
  • Year by year, Interest & Investment Income stood at $1.9 million in 2022, then jumped by 150.39% to $4.8 million in 2023, then jumped by 70.42% to $8.2 million in 2024, then plunged by 153.33% to -$4.4 million in 2025, then soared by 100.01% to $395.87 in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $395.87, -$4.4 million, and $457.54 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 48.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 19.51 Mn
10 Molecular Partners Ag 149.27 Mn 149.27 Mn - 395.87

Historic Data

Download Data
DateValue
Mar 31, 2026 395.87
Dec 31, 2025 -4.38 Mn
Sep 30, 2025 457.54
Jun 30, 2025 507.31
Mar 31, 2025 558.35
Dec 31, 2024 8.21 Mn
Sep 30, 2024 828.72
Jun 30, 2024 1,008.48
Mar 31, 2024 5,204.83
Dec 31, 2023 4.82 Mn
Sep 30, 2023 2,333.37
Jun 30, 2023 1.21 Mn
Mar 31, 2023 937.37
Dec 31, 2022 1.93 Mn
Sep 30, 2022 1,539.72
Jun 30, 2022 2.09 Mn
Mar 31, 2022 891.15
Dec 31, 2021 204,749.66
Sep 30, 2021 717.74
Jun 30, 2021 1.69 Mn